Interleukin-1 receptor type I gene-deficient bile duct-ligated mice are partially protected against endotoxin

Hepatology

Volumn 35, Issue 1, 2002, Pages 149-158

  Sewnath, Miguel E ^a   Van Der Poll, Tom ^a   Ten Kate, Fiebo J W ^a   Van Noorden, Cornelis J F ^b   Gouma, Dirk J ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; ENDOTOXIN; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT LIGATION; CHOLESTASIS; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE SEVERITY; HISTOPATHOLOGY; MOUSE; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

EID: 0036139951     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2002.30272     Document Type: Article

References (44)

1. Surgical experience of deeply jaundiced patients with bile duct obstruction
2. Factors predictive of survival in ampullary carcinoma
3. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: Pathology, complications, and outcomes
4. Measurement of operative plasma endotoxin levels in jaundiced and non-jaundiced patients
5. Endotoxin and bacteria in portal blood
6. Endotoxin concentrations following internal and external biliary drainage for obstructive jaundice
7. Endotoxemia and cholestasis
8. Reticulo-endothelial function in obstructive jaundice
9. Endotoxin-induced mortality in bile duct-ligated rats after administration of reconstituted high-density lipoprotein
10. Treatment with recombinant bactericidal/permeability-increasing protein to prevent endotoxin-induced mortality in bile duct-ligated rats
11. Cholestatic liver injury increases circulating TNF-alpha and IL-6 and mortality after Escherichia coli endotoxemia
12. Suppression of cellular immunity in obstructive jaundice is caused by endotoxins: A study with germ-free rats
13. Increased sensitivity to endotoxemia in the bile duct-ligated cirrhotic Rat
14. Obstructive jaundice in rats results in exaggerated hepatic production of tumor necrosis factor-alpha and systemic and tissue tumor necrosis factor-alpha levels after endotoxin
15. Biologic basis for interleukin-1 in disease
16. Endotoxin-induced cytokine gene expression and excretion in the liver
17. The release of tumor necrosis factor from endotoxin-stimulated rat Kupffer cells is regulated by prostaglandin E2 and dexamethasone
18. Interleukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock, but fails to alter host responses to sublethal endotoxemia
19. Phenotypic and functional characterization of mice that lack the type I receptor for IL-1
20. Sequestration of neutrophils in the hepatic vasculature during endotoxemia is independent of beta 2 integrins and intercellular adhesion molecule-1
21. Basic strategies for valid cytometry using image analysis
22. Augmented interleukin-1 betainduced depression of locomotor activity in cholestatic rats
23. Attenuated febrile response to lipopolysaccharide in rats with biliary obstruction
24. Acute obstructive cholangiopathy in interleukin-6 deficient mice: Compensation by leukemia inhibitory factor (LIF) suggests importance of gp-130 signaling in the ductular reaction
25. Cytokines tumor necrosis factor and interleukin-6 in experimental biliary obstruction in mice
26. The development and compensation of biliary cirrhosis in interleukin-6-deficient mice
27. Endotoxin, cytokines, and endotoxin binding proteins in obstructive jaundice and after preoperative biliary drainage
28. Plasma cytokine levels and monocyte activation in patients with obstructive jaundice
29. The abnormal lipid spectrum in malignant obstructive jaundice in relation to endotoxin sensitivity and the result of preoperative biliary drainage
30. Intestinal barrier dysfunction in clinical and experimental obstructive jaundice and its reversal by internal biliary drainage
31. Persistent systemic inflammatory response after stent insertion in patients with malignant bile duct obstruction
32. The influence of biliary obstruction and sepsis on reticuloendothelial function in rats
33. Effect of biliary decompression on reticuloendothelial function in jaundiced rats
34. Impaired bacterial killing in early obstructive jaundice
35. A recombinant human receptor antagonist to interleukin 1 improves survival after lethal endotoxemia in mice
36. Hematologic and immunomodulatory effects of an interleukin-1 receptor antagonist coinfusion during low-dose endotoxemia in healthy humans
37. Influence of IL-1 receptor blockade on the human response to endotoxemia
38. IL-1 type I receptor mediates acute phase response to turpentine, but not lipopolysaccharide, in mice
39. Effect of endotoxin in IL-1 beta-deficient mice
40. Differential sensitivity to Escherichia coli infection in mice lacking tumor necrosis factor p55 or interleukin-1 p80 receptors
41. Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: A phase III, randomized, double-blind, placebo-controlled, multicenter trial
42. Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial
43. Increased concentrations of tumour necrosis factor (TNF) and soluble TNF receptors in biliary obstruction in mice; soluble TNF receptors as prognostic factors for mortality
44. Effect of antitumour necrosis factor treatment on circulating tumour necrosis factor levels and mortality after surgery in jaundiced mice